Clinical Trials Directory

Trials / Unknown

UnknownNCT02808520

Social Inequalities in the Participation and Activity in Children and Adolescents With Hodgkin-lymphoma

Social Inequalities in the Participation and Activity in Children and Adolescents With Hodgkin-lymphoma. A Prospective Multicenter Cohort Study of Social and Personal Influencing Factors

Status
Unknown
Phase
Study type
Observational
Enrollment
700 (estimated)
Sponsor
Martin-Luther-Universität Halle-Wittenberg · Academic / Other
Sex
All
Age
10 Years – 18 Years
Healthy volunteers
Not accepted

Summary

Purpose of this study is to determine the influence of social factors on participation and activity among children and adolescents aged 10-18 years with hodgkin-lymphoma. Furthermore personal and treatment-related factors and their impact on participation will be explored.

Detailed description

Hodgkin-lymphoma is a rare malignancy among children and adolescents (about 140 each year in Germany) which is highly curable. Beside this therapeutic success, a lot of therapy-related long-term problems arise (e.g. fertility disorders, thyroid diseases, secondary malignancies). While most of the studies focused on mental and physical impairments, little attention has been drawn to social dimensions of health. Due to the disease and the requirements of the therapy, participation of children with hodgkin-lymphoma can be impaired acutely or chronically. This can be of serious consequences, because participation in daily life is an important component of the development of children and adolescents. To determine the influence of social, personal and treatment-related factors on participation, all patients who were actual treated in the international therapy study EuroNet-PHL-C2 in all of Germany (N ≈ 700) and their parents will be interviewed. Statistical analyses will be done using descriptive and multivariate methods taking account of treatment-related issues (e.g. stage of disease, chemotherapy, radiotherapy, progression/relapse).

Conditions

Timeline

Start date
2016-03-01
Primary completion
2020-02-01
Completion
2020-02-01
First posted
2016-06-21
Last updated
2016-06-21

Source: ClinicalTrials.gov record NCT02808520. Inclusion in this directory is not an endorsement.